HomeCompareROLA vs JEPQ

ROLA vs JEPQ: Dividend Comparison 2026

ROLA yields 0.87% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPQ wins by $23.9K in total portfolio value
10 years
ROLA
ROLA
● Live price
0.87%
Share price
$228.79
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$92.52
Full ROLA calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — ROLA vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodROLAJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ROLA + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ROLA pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ROLA
Annual income on $10K today (after 15% tax)
$74.30/yr
After 10yr DRIP, annual income (after tax)
$78.64/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, JEPQ beats the other by $1,751.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ROLA + JEPQ for your $10,000?

ROLA: 50%JEPQ: 50%
100% JEPQ50/50100% ROLA
Portfolio after 10yr
$32.9K
Annual income
$1,122.55/yr
Blended yield
3.42%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ROLA buys
0
JEPQ buys
0
No recent congressional trades found for ROLA or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricROLAJEPQ
Forward yield0.87%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$20.9K$44.8K
Annual income after 10y$92.52$2,152.59
Total dividends collected$902.00$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: ROLA vs JEPQ ($10,000, DRIP)

YearROLA PortfolioROLA Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$10,787$87.42$11,930$1,110.39$1.1KJEPQ
2$11,631$88.13$14,133$1,224.34$2.5KJEPQ
3$12,534$88.80$16,632$1,340.46$4.1KJEPQ
4$13,500$89.44$19,454$1,457.97$6.0KJEPQ
5$14,535$90.03$22,626$1,576.08$8.1KJEPQ
6$15,644$90.59$26,175$1,694.09$10.5KJEPQ
7$16,830$91.12$30,133$1,811.32$13.3KJEPQ
8$18,099$91.62$34,531$1,927.17$16.4KJEPQ
9$19,458$92.08$39,403$2,041.08$19.9KJEPQ
10$20,913$92.52$44,787$2,152.59$23.9KJEPQ

ROLA vs JEPQ: Complete Analysis 2026

ROLAStock

ROLA is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ROLA shares.

Full ROLA Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this ROLA vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ROLA vs SCHDROLA vs JEPIROLA vs OROLA vs KOROLA vs MAINROLA vs XYLDROLA vs QYLDROLA vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.